1.
Sher A, Wu S. Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis. AO [Internet]. 2011 Oct. 1 [cited 2026 May 20];50(7):997-1005. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32165